BIOMAT Database Logo BIOMAT Database Logo

JAK2V617F mutation is ubiquitously present in splanchnic vein thrombosis accompanying myeloproliferative syndromes. 2011

T Kanellopoulou, and A Alexopoulou, and J Koskinas

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009196 Myeloproliferative Disorders Conditions which cause proliferation of hemopoietically active tissue or of tissue which has embryonic hemopoietic potential. They all involve dysregulation of multipotent MYELOID PROGENITOR CELLS, most often caused by a mutation in the JAK2 PROTEIN TYROSINE KINASE. Disorder, Myeloproliferative,Disorders, Myeloproliferative,Myeloproliferative Disorder
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D013152 Splanchnic Circulation The circulation of blood through the BLOOD VESSELS supplying the abdominal VISCERA. Mesenteric Circulation,Circulation, Mesenteric,Circulation, Splanchnic,Circulations, Mesenteric,Circulations, Splanchnic,Mesenteric Circulations,Splanchnic Circulations

Related Publications

T Kanellopoulou, and A Alexopoulou, and J Koskinas
JAK2V617F mutation and myeloproliferative disorders in splanchnic vein thrombosis.
February 2011, Alimentary pharmacology & therapeutics,
T Kanellopoulou, and A Alexopoulou, and J Koskinas
JAK2V617F mutation in patients with splanchnic vein thrombosis.
June 2010, Digestive diseases and sciences,
T Kanellopoulou, and A Alexopoulou, and J Koskinas
JAK2V617F Mutation in Patient with Splanchnic Vein Thrombosis.
October 2020, Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion,
T Kanellopoulou, and A Alexopoulou, and J Koskinas
[Budd-Chiari syndrome and splanchnic vein thrombosis: masked myeloproliferative neoplasms and JAK2V617F].
January 2010, La Clinica terapeutica,
T Kanellopoulou, and A Alexopoulou, and J Koskinas
The clinical significance of JAK2V617F mutation for Philadelphia-negative chronic myeloproliferative neoplasms in patients with splanchnic vein thrombosis.
October 2012, Journal of thrombosis and thrombolysis,
T Kanellopoulou, and A Alexopoulou, and J Koskinas
Absence of JAK2V617F Mutated Endothelial Colony-Forming Cells in Patients With JAK2V617F Myeloproliferative Neoplasms and Splanchnic Vein Thrombosis.
June 2020, HemaSphere,
T Kanellopoulou, and A Alexopoulou, and J Koskinas
Splanchnic vein thrombosis in myeloproliferative neoplasms.
September 2013, British journal of haematology,
T Kanellopoulou, and A Alexopoulou, and J Koskinas
Thrombosis in myeloproliferative neoplasms with JAK2V617F mutation.
January 2013, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis,
T Kanellopoulou, and A Alexopoulou, and J Koskinas
Absence of JAK2V617F mutation in Chinese deep vein thrombosis patients without myeloproliferative neoplasms.
May 2012, Thrombosis research,
T Kanellopoulou, and A Alexopoulou, and J Koskinas
Splanchnic Vein Thrombosis in the Myeloproliferative Neoplasms.
June 2018, Current hematologic malignancy reports,
Copied contents to your clipboard!